Dr Anna Ralph

Senior clinical research fellow

Qualifications:

PhD, Australian National University, 2010; Fellow of the Royal Australasian College of Physicians, 2005; Diploma of Hygiene and Tropical Medicine, University of London, 2002; Master of Public Health, University of Sydney, 1999; Bachelor of Medicine and Bachelor of Surgery, University of New South Wales, 1996; Medical Science Honours Class 1, Australian National University, 1993; Bachelor of Medical Science, University of Tasmania, 1992.

Location:

Darwin - Royal Darwin Hospital campus

Biography:
Anna is staff specialist in infectious diseases and general medicine at the Royal Darwin Hospital and senior clinical research fellow at the Menzies School of Health Research. She is an honorary fellow of the Infectious Disease Society of Kota Kinabalu (Malaysia) and a member of the Australasian Society for Infectious Diseases Clinical Research Network.

Her research goals are to improve outcomes for people with diseases of poverty including tuberculosis and rheumatic fever. Her offshore research has included studies to improve knowledge of regional tuberculosis pathophysiology, epidemiology and treatment (in Indonesia and Malaysia). Her local research focus is on improving the management of acute rheumatic fever in the Northern Territory.
  1. Ralph, A.P., Waramori G., Pontororing G.J., Kenangalem E., Wiguna A., Sandjaja, Tjitra, E., et al. (2013) L-arginine and Vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double-blind, placebo-controlled trial. PLoS ONE, 8(8).
  2. Ralph, A.P., Lucas, R.M.,& Norval. (2013). Vitamin D and solar ultraviolet radiation in the risk and treatment of tuberculosis. Lancet Infectious Diseases 13, 77-88.
  3. Ralph, A.P., Fittock, M., Schultz, R., Thompson, D., Dowden, M., Clemens, et al. (2013). Improvement in rheumatic fever and rheumatic heart disease management and prevention using a health centre-based continuous quality improvement approach. BMC Health Services Research, 13, 525.
  4. Ralph, A.P., Kenangalem, E., Waramori, G., Pontororing, G.J., Sandjaja, Tjitra, E., et al. (2013). High morbidity during treatment and residual pulmonary disability in pulmonary tuberculosis: under-recognised phenomena. PLoS One, 8(11).
  5. Ralph, A.P., & Lucas, R.M,. Vitamin D and tuberculosis: hope or hype? Medical Journal of Australia,199(10), 648-9.
  6. Ralph, A.P., Yeo, T.W., Salome, C.M., Waramori, G., Pontororing, G.J., Kenangalem, E., et al. (2013). Impaired Pulmonary Nitric Oxide Bioavailability in Pulmonary Tuberculosis: Association with Disease Severity and Delayed Mycobacterial Clearance with Treatment. Journal of Infectious Diseases, (4), 616-26.
  7. Pontororing, G.J., Kenangalem, E., Lolong, D.B., Waramori, G., Sandjaja, Tjitra, E., Price, et al. (2010). The burden and treatment of HIV in tuberculosis patients in Papua Province, Indonesia: a prospective observational study. BMC Infectious Diseases, 10, 362.
  8. Ralph, A.P., Ardian, M., Wiguna, A., Maguire, G.P., Becker, N.G., Drogumuller, G., et al. (2010). A simple, valid, numerical score for grading chest X-ray severity in adult smear positive pulmonary tuberculosis. Thorax, 65, 863-869.
  9. Ralph, A.P., Anstey, N.M., & Kelly, P.M. (2009). Tuberculosis into the 2010s: is the glass half full? Clinical Infectious Diseases, 49(4),574-83.
  10. Ralph, A.P., Kelly, P.M., & Anstey, N.M. (2008). Arginine and Vitamin D: novel adjunctive immunotherapies in tuberculosis. Trends Microbiology, 16(7):336-344.
Click here to view more Anna Ralph publications in PubMed.
  1. Research reveals new target to fight tuberculosis

    Research reveals new target to fight tuberculosis

    Date

    New research from the Menzies School of Health Research could open the door to the development of new treatments for Tuberculosis (TB).

  2. Disease of the month: tuberculosis

    Disease of the month: tuberculosis

    Date

    With a history as long as mankind’s, TB lies dormant in one third of our global population.

  3. The Conversation: Lung gas holds clue for future tuberculosis treatment

    The Conversation: Lung gas holds clue for future tuberculosis treatment

    Date

    Australian researchers have uncovered a link between low levels of the gas nitric oxide in the lungs of tuberculosis patients and the body’s ability to fight the deadly disease, opening the door to potential new treatments.

  4. Journal of Infectious Diseases: Impaired Pulmonary Nitric Oxide Bioavailability in Pulmonary Tuberculosis

    Journal of Infectious Diseases: Impaired Pulmonary Nitric Oxide Bioavailability in Pulmonary Tuberculosis

    Date

    Impaired Pulmonary Nitric Oxide Bioavailability in Pulmonary Tuberculosis: Association with Disease Severity and Delayed Mycobacterial Clearance with Treatment.

  5. Funding boost to tackle health challenges in northern Australia

    Funding boost to tackle health challenges in northern Australia

    Date

    Work will begin to help close critical gaps in healthcare across northern Australia as the result of a $6m grant awarded today to Menzies School of Health Research (Menzies) by the National Health and Medical Research Council (NHMRC).